Diana Schwarzbein is another M.D. that has come to realize that low carb is what works. See reviews at The Schwarzbein Principle. The book is based on her work with insulin-resistant patients with Type II diabetes. She concludes that low-fat diets cause heart attacks, eating fat makes you lose body fat, and it's important to eat high-cholesterol foods every day.
On the surface, the Keto diet and the Paleo diet, two of the most popular diets out there, seem pretty similar. Both are low-carb plans that don't allow you to eat some of your favorite foods, such as cookies, pizza, and cereal. But there are actually some pretty important differences between the two diets that you should know, so you can figure out if either of them are right for you.
This traditional legal effort is paired with an aggressive social-media operation run by two men, Russ Greene and Russell Berger. At CrossFit headquarters in Santa Cruz, they are known as the Russes.The Russes assist the company's conventional corporate social-media efforts (running the Twitter handle, promoting company news on the CrossFit Facebook page) while also closely monitoring what they call "the wide world of Internet assholes": chronic complainers, trolls, Wikipedia page editors, cynical bloggers, even the American College of Sports Medicine, which the Russes and Glassman believe has it in for CrossFit. When the Russes feel any of these parties go over the line, their approach is simple: They obliterate them. (See "Social Media, CrossFit Style.")
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”